Black Bird Biotech, Inc.
BBBT
$0.00
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 41.64% | 62.30% | 60.19% | 72.79% | 50.23% |
| Total Depreciation and Amortization | 136.49% | 132.62% | 383.84% | -96.64% | -32.52% |
| Total Amortization of Deferred Charges | 100.00% | 1,193.22% | -- | -67.79% | -110.57% |
| Total Other Non-Cash Items | -3.10% | -99.69% | -95.51% | -85.91% | -45.74% |
| Change in Net Operating Assets | -24.01% | 474.36% | -110.58% | 9,200.00% | 326.92% |
| Cash from Operations | 96.07% | 96.24% | 75.13% | 68.69% | 56.93% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -91.39% | -90.26% | -- | 183.13% | -47.89% |
| Total Debt Repaid | 80.79% | 4.82% | 55.70% | 71.40% | 60.86% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -97.18% | -95.80% | 1,526.32% | 108.80% | -86.74% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -107.30% | 99.06% | 90.56% | 93.23% | -98.18% |